The nine new drug pricing deals the Trump administration announced with midsize manufacturers Monday came together despite fears within segments of the industry about how price concessions could affect smaller companies' bottom lines.
Why it matters: The administration has been pressuring midsize companies to fall in line with its pricing regime, as it expands the "most favored nation" deals it's already struck with 17 large drug manufacturers.
A new independent evaluation finds that leading AI models are far less likely than earlier versions to explicitly encourage suicide or reinforce delusions.
Yes, but: The study also found most models too willing toassist with suicide-related creative writing, farewell notes and other task-based requests even when a user's distress should have been apparent.
Why it matters: Saving the world with AI-designed cures is better than being blamed for ruining the environment or driving up Americans' utility bills.
